Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Not Rated'. Macroaxis provides Bharat Immunologicals buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIBCL positions. The advice algorithm takes into account all of Bharat Immunologicals available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BIBCL buy-and-hold prospective. Check also Trending Equities.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a risk adjusted performance of 0.0023, jensen alpha of (0.047607), total risk alpha of (0.034574), sortino ratio of 0.0 and treynor ratio of (0.07)We provide buy or sell advice to complement the prevailing expert consensus on Bharat Immunologicals. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income .
Bharat Immunologicals Trading Alerts and Improvement Suggestions
|Bharat Immunologicals is not yet fully synchronised with the market data|
|Bharat Immunologicals generates negative expected return over the last 30 days|
|Bharat Immunologicals has high historical volatility and very poor performance|
|The company reported revenue of 836.45M. Net Loss for the year was (55.57M) with profit before overhead, payroll, taxes, and interest of 103.65M.|
Bharat Immunologicals Returns Distribution Density
|Mean Return||0.04||Value At Risk||5.03|
|Potential Upside||3.88||Standard Deviation||4.99|